文献速递关节外科

大麻使用不影响全髋关节置换术后的结局

Cannabis Use Does Not Affect Outcomes After Total Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2023-03-20

本研究回顾性分析了74例自报使用大麻的原发性全髋关节置换术患者,并与匹配的未使用大麻患者比较,发现两组在Harris髋关节评分、HOOS JR评分、住院及门诊阿片类药物用量、住院时长、再入院和再手术方面均无差异。作者结论认为自报大麻使用不影响全髋关节置换术后1年结局,但需进一步研究以确定围手术期大麻使用的疗效和安全性。

要点

  • 自报大麻使用与全髋关节置换术后1年Harris髋关节评分和HOOS JR评分无差异。
  • 大麻使用组与对照组在住院阿片类药物用量、门诊阿片类药物处方量、住院时长、再入院和再手术方面无差异。
  • 作者认为需进一步研究以确定全髋关节置换术围手术期大麻使用的疗效和安全性。

核心结论

  • 自报大麻使用不影响全髋关节置换术后1年结局。
  • 需进一步研究以确定全髋关节置换术后围手术期大麻使用的疗效和安全性,以帮助骨科医生指导患者。

研究设计与样本

  • 回顾性研究,纳入2014年1月至2019年12月在同一机构接受初次全髋关节置换术、至少随访1年且自报使用大麻的74例患者。
  • 排除有酒精或非法药物滥用史的患者。
  • 根据年龄、体重指数、性别、Charlson合并症指数、保险状态以及尼古丁、麻醉药、抗抑郁药或苯二氮䓬类药物使用情况,与未自报使用大麻的全髋关节置换术患者进行匹配对照。

主要发现

  • 两组在术前、术后及变化的Harris髋关节评分或HOOS JR评分方面无差异。
  • 住院阿片类药物用量(吗啡毫克当量):大麻组102.4 vs 对照组101,P=0.92。
  • 门诊阿片类药物处方量(吗啡毫克当量):大麻组119 vs 对照组156,P=0.11。
  • 住院时长:大麻组1.4天 vs 对照组1.5天,P=0.32。
  • 再入院:大麻组4例 vs 对照组4例,P=1.0;再手术:大麻组2例 vs 对照组1例,P=0.56。

局限性

  • 需进一步研究以确定全髋关节置换术后围手术期大麻使用的疗效和安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cannabis use in patients undergoing arthroplasty has increased with ongoing legalization throughout the United States. The purpose of this study was to report total hip arthroplasty (THA) outcomes in patients self-reporting cannabis use. METHODS: There were 74 patients who underwent primary THA from January 2014 to December 2019 at a single institution with minimum 1-year follow-up who had their self-reported cannabis use retrospectively reviewed. Patients who had a history of alcohol or illicit drug abuse were excluded. A match control was conducted based on age; body mass index; sex; Charlson Comorbidity Index; insurance status; and use of nicotine, narcotics, antidepressants, or benzodiazepines to patients undergoing THA who did not self-report cannabis use. Outcomes included Harris Hip Score (HHS), Hip Disability and Osteoarthritis Outcome Score for Joint Reconstruction (HOOS JR), in hospital morphine milligram equivalents (MMEs) consumed, outpatient MMEs prescribed, in hospital lengths of stay (LOS), postoperative complications, and readmissions. RESULTS: There was no difference in the preoperative, postoperative, or change in Harris Hip Score or HOOS JR between cohorts. There was also no difference in hospital MMEs consumed (102.4 versus 101, P = .92), outpatient MMEs prescribed (119 versus 156, P = .11) or lengths of stay (1.4 versus 1.5 days, P = .32). Also, readmissions (4 versus 4, P = 1.0) and reoperations (2 versus 1, P = .56) were not different between groups. CONCLUSION: Self-reported cannabis use does not influence 1-year outcomes after THA. Further studies are warranted to determine the efficacy and safety of perioperative cannabis use after THA to help guide orthopaedic surgeons in counseling patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Hegde V, Bracey DN, Pollet AK, et al. Cannabis Use Does Not Affect Outcomes After Total Hip Arthroplasty. J Arthroplasty. 2023. PMID: 36940759. doi:10.1016/j.arth.2023.03.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。